CARLIE VAN VOORST: Open Payments
NPI 1841961802 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,202 in 63 payments from 19 companies in 2025. Trend: 2023 $1,346 · 2024 $1,419 · 2025 $1,202
Food & beverage: $1,202
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $290 |
| Otsuka America Pharmaceutical, Inc. | 11 | $276 |
| PFIZER INC. | 5 | $114 |
| Sumitomo Pharma America, Inc. | 5 | $100 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Lundbeck LLC | 3 | $55 |
| Eisai Inc. | 1 | $49 |
| Lilly USA, LLC | 2 | $37 |
| Medtronic, Inc. | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $25 |
Products named: REXULTI, UBRELVY, QULIPTA, GEMTESA, NURTEC ODT, VRAYLAR, Leqembi, Auvelity.
Industry payments across IN — which companies pay providers there.
